← Back to Clinical Trials
Recruiting NCT06005181

NCT06005181 The Synchrony Study: Examining Music Training for Children With FASD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06005181
Status Recruiting
Phase
Sponsor The Mind Research Network
Condition Fetal Alcohol Spectrum Disorders
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2023-10-02
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 16 Years
Study Type INTERVENTIONAL
Interventions
Music listeningPiano training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2023-10-02 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to examine if music training improves behavioral or cognitive performance in children with prenatal alcohol exposure who meet research criteria for a fetal alcohol spectrum disorder. The main questions it aims to answer are: * Does music training improve behavioral regulation for children with an FASD * Does music training improve cognitive performance (attention and working memory) for children with an FASD. The study has two interventions for each participant: music listening and piano training. Each participant will either practice piano daily for 12 weeks or listen to pre-selected music daily for 12 weeks. The order of the interventions will be randomized across participants. Assessment will occur before and after participation in each 12 week intervention.

Eligibility Criteria

Inclusion Criteria: * Children must receive a research designation of FASD * Children must have confirmed prenatal alcohol exposure Exclusion Criteria: * Children with other confirmed developmental disorders that are not deemed associated with FASD (e.g. autism spectrum disorder, Down Syndrome). Children with attention deficits (e.g. ADHD) are not excluded. * Children with neurological disorders (epilepsy, cerebral palsy, etc.) * Children who have experienced a traumatic brain injury with loss of consciousness \>10 minutes * Children with intelligence quotient scores \<70 * Children who are, or become, a ward of the state; however children with a legal representative who can consent on their behalf will not be excluded * Children with ongoing music training outside of school or \>1 year of prior private music lessons.

Contact & Investigator

Central Contact

Julia M Stephen, PhD

✉ JSTEPHEN@MRN.ORG

📞 505-272-5028

Frequently Asked Questions

Who can join the NCT06005181 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 16 Years, studying Fetal Alcohol Spectrum Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06005181 currently recruiting?

Yes, NCT06005181 is actively recruiting participants. Contact the research team at JSTEPHEN@MRN.ORG for enrollment information.

Where is the NCT06005181 trial being conducted?

This trial is being conducted at Albuquerque, United States.

Who is sponsoring the NCT06005181 clinical trial?

NCT06005181 is sponsored by The Mind Research Network. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology